Head-to-head · Cost-Efficiency Index
Roen Rx vs 10rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Roen Rx
Cost-first shoppers who want insured shoppers chasing a low brand-name copay via RoenRx's insurance coordination, with a compounded fallback.
Visit Roen Rx10rx
Shoppers comfortable prepaying a full 3-month block once pricing is revealed in the quiz flow.
Visit 10rxThe verdict
Roen Rx and 10rx tie on the Cost-Efficiency Index at 46/100, so neither wins outright on the numbers. For most shoppers we'd start with Roen Rx (ranked #454, a hair above #455) — Cost-first shoppers who want insured shoppers chasing a low brand-name copay via RoenRx's insurance coordination, with a compounded fallback. But 10rx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Roen Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Roen Rx | 10rx |
|---|---|---|
| Cost-Efficiency Index | 46/100 | 46/100 |
| Semaglutide / mo | $151/mo (starting dose, 3-month plan, plus a separate fee, compounded) | Not disclosed |
| Tirzepatide / mo | $216/mo (starting dose, plus a separate fee, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,812 | — |
| Tirzepatide / yr (modeled) | $2,592 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #454 | #455 |
Roen Rx
46/100Where the value is
- Insurance coordination path can bring brand-name GLP-1s down to as low as $25/mo for covered patients
- Both compounded and brand-name (Ozempic, Wegovy, Zepbound, Mounjaro) options on one platform
- Explicitly serves all 50 states and DC
The tradeoffs
- The advertised LegitScript badge on the homepage is literally commented out in the page's HTML source and never renders on the live site — despite being present in source, it is not a real, visible certification a visitor sees
- Medication cost and membership fee are billed separately; the membership's regular (non-promotional) monthly price is never disclosed anywhere checked, only the '$39 first month' discount
Regulatory note: the FDA issued a warning letter to Roen Health, Inc. dba RoenRx in June 2026. We still list and link to Roen Rx; you should know the letter is on the public record before you decide.
10rx
46/100Where the value is
- Named founder physician (Dr. Michael Wasef, MD) with a public provider roster
- Flat price promise -- 'your price stays the same across available strengths' even if dose changes
- Free shipping advertised
The tradeoffs
- No dollar pricing published anywhere on the public site -- fully gated behind the quiz/checkout
- Quarterly-only billing structure (3 months upfront) makes month-to-month cost comparison impossible without completing intake
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.